| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |